Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

05/24/2012 | 07:58am US/Eastern
Recommend:
0

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

Recommend :
0
React to this article
Latest news on AUXILIUM PHARMACEUTICALS,
4d ago AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
4d ago AUXILIUM PHARMACEUTICALS : To Present CCH Data For Concurrent Treatment Of Multi..
5d ago AUXILIUM PHARMACEUTICALS : Announces Positive Data From Phase 2a Study Of CCH In..
5d ago AUXILIUM PHARMACEUTICALS : To Present At The Morgan Stanley Healthcare Conferenc..
08/21 AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
08/21 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
08/21 AUXILIUM PHARMACEUTICALS : Announces Positive Data From Phase 2a Study Of CCH In..
08/18 AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial..
08/11 AUXILIUM PHARMACEUTICALS : Change in Directors or Principal Officers, Regulation..
08/11 AUXILIUM PHARMACEUTICALS : Appoints Andrew Saik Chief Financial Officer
Advertisement
Chart
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF